Spero Therapeutics
SPRO
#9152
Rank
โ‚น5.33 B
Marketcap
โ‚น97.91
Share price
-2.52%
Change (1 day)
-1.25%
Change (1 year)

Spero Therapeutics (SPRO) Fails to deliver data

Key failure to deliver metrics for Spero Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Spero Therapeutics (SPRO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Spero Therapeutics (SPRO) - since 2017

Volume in USD (price x number of shares), data since 2017

Spero Therapeutics (SPRO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น0.25 M-70.7%
2023โ‚น0.85 M-88.65%
2022โ‚น7.55 M81.02%
2021โ‚น4.17 M23.57%
2020โ‚น3.37 M2331.08%
2019โ‚น0.13 M-93.38%
2018โ‚น2.09 M-76.81%
2017โ‚น9.04 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น0.04 Mโ‚น0.21 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น47.65 Mโ‚น0.36 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.46 Mโ‚น0.18 B๐Ÿ‡จ๐Ÿ‡ฆ Canada